You just read:

U.S. FDA Accepts Allergan's New Drug Application for Bimatoprost Sustained-Release in Patients with Open-Angle Glaucoma or Ocular Hypertension

News provided by

Allergan plc

Jul 17, 2019, 07:30 ET